Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL(legacy) | 184 |
| A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL(legacy) | 102 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph plus CML or relapsed/refractory Ph plus ALL | 1 | 6 | 1 | 5 | 1 | 3 | 1 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| United States | 68 |
| Australia | 33 |
| China | 18 |
| France | 9 |
| Netherlands | 9 |
| Vietnam | 5 |
| Ukraine | 3 |
| Germany | 1 |
| Spain | 1 |
| Ireland | 1 |
Top City Views
| Views | |
|---|---|
| Kaleen | 30 |
| Ashburn | 11 |
| Rotterdam | 8 |
| Zhengzhou | 8 |
| Hanoi | 5 |
| Fairfield | 4 |
| New York | 3 |
| Beijing | 2 |
| Des Moines | 2 |
| Jacksonville | 2 |